-
Jio Platforms
1,490.00 1,423.80(%) -
Reliance Industries
1,182.00 1,611.20(%) -
Tube Investments
2,098.60 2,006.00(%) -
NSE
1,795.00 1,878.00(%) -
PTC Industries
24,750.00 26,049.95(%) -
Dalmia BharatLtd
1,403.50 1,464.85(%) -
Aeroflex
579.00 613.50(%) -
Pidilite Inds.
1,429.05 1,707.95(%) -
The Bombay Burmah
1,175.60 1,108.20(%) -
Birlasoft Ltd
352.25 473.75(%) -
Billionbrains
193.00 227.00(%) -
Cholaman.Inv.&Fn
1,589.95 1,952.00(%) -
Bajaj Finance
932.45 1,177.60(%) -
Max Healthcare
848.40 797.00(%) -
Adani Ports
1,867.75 1,891.80(%) -
M & M Fin. Serv.
256.60 253.30(%) -
HDFC Bank
678.05 668.90(%) -
Coromandel Inter
1,702.00 1,652.00(%) -
Acutaas Chemical
4,003.00 3,977.00(%) -
Kotak Mah. Bank
455.50 453.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aspira Pathlab & Diagnostics Ltd Healthcare
- Indian Private
- BSE Code : 23958.0
- ISIN : INE500C01017
-
Today’s Low
118.75 -
Today’s High
130.40
-
Open
118.75 -
Perv Close
125.00 -
52W Low
49.00 -
52W High
149.99
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
129.33
-
Div & Yield %
0.00
-
Book Value(₹)
7.09
-
Debt-Equity Ratio
0.52
-
AGM Date
28-Oct-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
129.33
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
10.29
-
BV (₹)
7.10
-
Sales( ₹ in Cr.)
24.98
-
NP (in Cr.)
0.05
-
NP Var(%)
-98.0
-
Div%
0.0
-
CPS (₹)
1.50
-
EPS (₹)
0.00
-
Traded Value (₹ in Lakhs)
129.33
-
52 Week High
149.99
-
52 Week Low
49.00
-
Price BSE
126.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
129.33
-
P/C Ratio
81.60
-
P/E Ratio
2,528.10
-
Price Vs.BV
0.00
-
08-Oct-2026( 02:31)
Corporate News - Aspir... - <p>Aspira Pathlab & Diagnostic...
-
23-Sep-2026( 02:20)
Corporate News - Aspir... - <p>Aspira Pathlab & Diagnostic...
-
12-Sep-2026( 05:52)
Hot Pursuit - Aspir... - <p>Aspira Pathlab & Diagnostic...
-
07-Sep-2026( 02:17)
Corporate News - Aspir... - <p>Aspira Pathlab & Diagnostic...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 24.98 | 22.00 | 13.20 | 14.46 | 19.54 | 15.21 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 24.98 | 22.00 | 13.20 | 14.46 | 19.54 | 15.21 |
| Other Income | 0.52 | 0.39 | 0.42 | 0.32 | 0.09 | 0.20 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 25.50 | 22.39 | 13.62 | 14.78 | 19.63 | 15.41 |
| EXPENDITURE : | ||||||
| Raw Materials | 4.52 | 3.70 | 2.62 | 2.50 | 3.14 | 2.63 |
| Power and Fuel Cost | 0.36 | 0.33 | 0.26 | 0.24 | 0.21 | 0.13 |
| Employee Cost | 8.78 | 7.33 | 6.20 | 5.59 | 5.02 | 4.03 |
| Other Manufacturing Expenses | 2.71 | 2.68 | 0.97 | 1.91 | 1.40 | 2.64 |
| Selling and Administration Expenses | 4.62 | 2.88 | 3.43 | 2.59 | 2.94 | 2.16 |
| Miscellaneous Expenses | 2.53 | 1.56 | 0.92 | 0.03 | 0.46 | 0.10 |
| Employee Benefit Expenses | 8.78 | 7.33 | 6.20 | 5.59 | 5.02 | 4.03 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 23.52 | 18.48 | 14.39 | 12.87 | 13.17 | 11.69 |
| Operating Profit | 1.98 | 3.92 | -0.76 | 1.92 | 6.47 | 3.72 |
| Interest | 0.39 | 0.35 | 0.37 | 0.42 | 0.37 | 0.89 |
| Gross Profit | 1.59 | 3.57 | -1.13 | 1.50 | 6.10 | 2.83 |
| Depreciation | 1.54 | 1.49 | 1.54 | 1.59 | 1.64 | 1.44 |
| Profit Before Tax | 0.05 | 2.08 | -2.67 | -0.09 | 4.46 | 1.39 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 0.05 | 2.07 | -2.67 | -0.09 | 4.46 | 1.38 |
| Extraordinary Items | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 0.05 | 2.10 | -2.67 | -0.09 | 4.46 | 1.38 |
| Adjustment below Net Profit | -0.04 | 0.00 | 0.07 | 0.05 | 0.02 | 0.13 |
| P & L Balance brought forward | -12.04 | -14.11 | -11.50 | -11.46 | -15.94 | -17.45 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -12.02 | -12.04 | -14.11 | -11.50 | -11.46 | -15.94 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 0.05 | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 |
| Earnings Per Share(Adj)-Unit Curr | 0.05 | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 |
| Book Value | 7.09 | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 |
| Book Value(Adj)-Unit Curr | 7.09 | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 |
